HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Business (Wellness)

Set Alert for Business {Wellness}

Deals

Set Alert for Deals {Wellness}

Latest From Wellness & Deals

ChromaDex Rides Nestle Deal To 14% Q4 Growth; Mannatech, USANA End Year In Slumps

ChromaDex reports Niagen ingredient sales growth propelled by upfront minimum purchase from Nestlé Health Science; and Mannatech and USANA both reported larger full-year sales dips after ending 2022 in slumps.

Dietary Supplements Sales & Earnings

Reaching 'Transformation' In Turnaround Phase 1, Perrigo Looks To Build On Its Accomplishments

Day after releasing Q4 and full-year results, Perrigo announced launch of next chapter in its “3/5/7” makeover strategy. It reached annual growth of 3% for top line revenues in phase 1, aims for 5% operating income and 7% earnings per share growth in phase 2.

Sales & Earnings M & A

UK’s OptiBiotix Offers GoFigure Prebiotic Range To Slim Down Saudi Arabia’s ‘Alarming’ Obesity Rates

Thanks to a deal with local pharmacy chain Nahdi Medical, slimmers in the Kingdom of Saudi Arabia will soon be able to buy GoFigure shakes and bars, which contain OptiBiotix Health's trademarked SlimBiome prebiotic.

Saudi Arabia Wellness
See All

Strategy

Set Alert for Business Strategy {Wellness}

Latest From Wellness & Business Strategies

US FDA Supplement Facility Inspection Numbers Back To Typical Along With GMP Problems Found

Supplement facility GMP inspections by FDA in 2022 along with the frequency of form 483s sent to firms following inspections return to roughly pre-pandemic annual numbers after dipping during 2020 and 2021.

Dietary Supplements FDA

People On The Move: Appointments At GSCF, Bayer, Shop Apotheke

A round-up of the latest appointments in the consumer health industry: the Global Self-Care Federation elects J&J's Raghunandanan as its chair; Bayer Consumer Health makes changes to its medical leadership; and Shop Apotheke hires ex-DocMorris CEO to lead company.

Executive Changes Leadership

Empowered By Evidence Debuts Lists Of Natural Health Ingredients Meeting Its Standards

Global nonprofit supporting evidence-based product development in natural health sector and American Botanical Council announce database intended to help consumers, researchers and health care professionals make natural product choices based on specific scientific and clinical evidence.

Dietary Supplements Research & Development
See All

Sales & Earnings

Set Alert for Sales & Earnings {Wellness}

Latest From Wellness & Sales & Earnings

ChromaDex Rides Nestle Deal To 14% Q4 Growth; Mannatech, USANA End Year In Slumps

ChromaDex reports Niagen ingredient sales growth propelled by upfront minimum purchase from Nestlé Health Science; and Mannatech and USANA both reported larger full-year sales dips after ending 2022 in slumps.

Dietary Supplements Sales & Earnings

Reaching 'Transformation' In Turnaround Phase 1, Perrigo Looks To Build On Its Accomplishments

Day after releasing Q4 and full-year results, Perrigo announced launch of next chapter in its “3/5/7” makeover strategy. It reached annual growth of 3% for top line revenues in phase 1, aims for 5% operating income and 7% earnings per share growth in phase 2.

Sales & Earnings M & A

Double-Digit Power Brand Growth Helps Haleon Beat Guidance In 2022

The growth of its nine power brands helped Haleon outstrip its sales guidance in 2022. While operating profit also improved, the firm was unable to hit its margin guidance, a miss it blamed on adverse transactional foreign currency.

Europe Asia Pacific
See All

Litigation

Set Alert for Legal Issues

Latest From Wellness & Legal Issues

Health Care Professionals Settle With FTC Over COVID-19 Claims For Direct Seller’s Supplements

Three distributors made claims doTerra's essential oils and supplements could treat or prevent COVID-19 in early 2022webinars. They also underscored medical expertise in recommending products.

Coronavirus COVID-19 Ad Complaints

FTC Returns Nearly $1M To Consumers Duped By NutraClick, A Relic Of Section 13(b) Authority

The agency laments that such refunds to wronged consumers will be more difficult to provide since the US Supreme Court ruled in 2021 that it lacks authority under Section 13(b) of the FTC Act to seek monetary relief in federal court. NutraClick has agreed to be banned from negative option marketing as part of its September 2020 settlement with the FTC.

Legal Issues Advertising, Marketing & Sales

Hydrolyzed Collagen Supplement Firm Agrees To Order Barring Claims To Grow Bone, Cartilage

Claims of bone and cartilage growth, along with relief of joint pain, shot down by FTC. But company says claims “are adequately substantiated by existing studies and scientific literature.”

Ad Complaints Dietary Supplements
See All
UsernamePublicRestriction

Register